Anthony Almada, MSc
Anthony has worked in the natural products industry since 1975. He obtained his MSc in Nutritional Sciences at UC Berkeley, completing a research thesis in antioxidant and exercise biochemistry. In 1990 he co-created the “thermogenic” category of dietary supplements. In 1992 he co-founded EAS, (sold to Abbott in 2005 for $320 million) introducing creatine monohydrate and evidence-based performance nutrition. He has collaborated on over 90 university- and private research center-based clinical trials. He is a frequent expert in class action litigation has been an invited presenter at the FTC and the NIH, and been quoted in the New York Times, Forbes, and Bloomberg. He leads IMAGINutrition, Inc., a think tank focusing upon innovation/intellectual properties, strategic clinical research, and demand creation across dietary supplements, conventional and medical foods, beverages, cosmetics, and animal supplements and foods.